✅ Model Answer:
• Diagnosis: Primary intestinal lymphangiectasia (protein-losing enteropathy).
• Evidence: Hypoalbuminemia, elevated fecal α1-antitrypsin (protein loss), dilated lacteals on small bowel biopsy, lymphopenia, negative anti-tTG (excludes celiac), normal fecal elastase (excludes pancreatic insufficiency).
• Next step: Start low-fat, high-MCT (medium-chain triglyceride) diet. Monitor for fat-soluble vitamin deficiencies (ADEK). Consider endoscopic examination and lymphangiography if secondary causes suspected.

✅ Model Answer:
• Definition: Dilatation of intestinal lymphatics leading to leakage of lymph into the intestinal lumen.
• Types:
- Primary: Congenital (idiopathic, often sporadic).
- Secondary: Caused by conditions that obstruct lymph flow (e.g., constrictive pericarditis, retroperitoneal fibrosis, lymphoma, Crohn disease, sarcoidosis).
• Pathophysiology: Dilated lacteals → increased intestinal lymphatic pressure → rupture → loss of lymph (rich in proteins, lymphocytes, chylomicrons) into the gut lumen.
• Consequences:
- Hypoproteinemia: Loss of albumin, IgG, IgM, IgA.
- Lymphopenia: Loss of T-cells (lymphocytes).
- Fat malabsorption: Loss of chylomicrons → steatorrhea and fat-soluble vitamin deficiencies.
- Hypocalcemia: Due to vitamin D deficiency and albumin loss.

✅ Model Answer:
• Classic features:
- Edema: Peripheral (legs, face), due to hypoalbuminemia.
- Chronic diarrhea: Steatorrhea (fatty stools) – bulky, foul-smelling, floats.
- Failure to thrive: Poor weight gain, malnutrition.
- Lymphopenia: Increased susceptibility to infections.
- Hypoalbuminemia.
• Other features:
- Chylous ascites: Milky fluid in the peritoneal cavity.
- Chylothorax.
- Fatigue, muscle wasting.
- Abdominal distention.
- Recurrent infections (due to loss of immunoglobulins and T-lymphocytes).
- Fat-soluble vitamin deficiencies (A, D, E, K) → osteopenia, bleeding, night blindness.

✅ Model Answer:
• Small bowel biopsy (EGD):
- Endoscopic appearance: White/yellowish villi due to lacteal dilatation.
- Histology: Dilated lacteals in the lamina propria (hematoxylin-eosin stain).
• Fecal α1-antitrypsin:
- Elevated: Indicates protein-losing enteropathy (>0.9 mg/g stool).
• Serum tests:
- Albumin: Low.
- Total protein: Low.
- Lymphocyte count: Low (lymphopenia).
- Immunoglobulins: Low IgG, IgM, IgA.
- Fat-soluble vitamins: Low (A, D, E, K).
• Lymphangiography: To identify dilated lymphatics (rarely done now).
• Secondary causes: Evaluate for cardiac (echocardiogram), retroperitoneal, or malignant causes.

✅ Model Answer:
• Dietary management:
- Low-fat diet: Reduces lymphatic pressure (long-chain triglycerides increase lymph flow).
- High-MCT (medium-chain triglycerides) oil: MCT is absorbed directly into the portal circulation (bypassing lymphatics), providing calories and reducing steatorrhea.
- MCT-based formula: For children who cannot tolerate oral diet.
- Fat-soluble vitamin supplementation: ADEK vitamins (water-miscible forms) to prevent deficiencies.
• Nutritional support:
- Calorie supplementation: To promote weight gain.
- Elemental or semi-elemental formula: If severe malabsorption.
• Secondary causes: Treat the underlying condition (e.g., cardiac surgery for constrictive pericarditis).
• Albumin infusion: If severe edema and symptomatic hypoalbuminemia.
• Immunoglobulin replacement: If recurrent infections.

✅ Model Answer:
• Malnutrition:
- Failure to thrive, growth retardation.
- Muscle wasting, fatigue.
• Fat-soluble vitamin deficiencies:
- Vitamin A: Night blindness, xerophthalmia.
- Vitamin D: Rickets, osteopenia, hypocalcemia.
- Vitamin E: Neurologic symptoms (ataxia, neuropathy).
- Vitamin K: Bleeding tendency, prolonged PT.
• Immunodeficiency:
- Lymphopenia: Increased susceptibility to infections (bacterial, viral).
- Hypogammaglobulinemia: Recurrent respiratory infections.
• Edema: Peripheral edema, ascites, pleural effusion.
• Steatorrhea: Chronic diarrhea, dehydration.
• Psychosocial impact: Dietary restrictions, frequent hospitalizations.

✅ Model Answer:
• Prognosis:
- Good with dietary management and nutritional support.
- Primary: Lifelong dietary therapy (low-fat, high-MCT).
- Secondary: Prognosis depends on the underlying cause (e.g., lymphoma, cardiac).
- Growth: Improves with adequate calorie and protein intake.
- Infections: Risk decreases with improved nutrition and immunoglobulin replacement.
- Spontaneous resolution: Rare; most require lifelong management.
• Long-term follow-up:
- Monitor growth: Height, weight, BMI.
- Monitor nutritional status: Albumin, protein, lymphocyte count.
- Monitor fat-soluble vitamins: Vitamin A, D, E, K levels.
- Monitor for infections.
- Dietary counseling: Ensure compliance with low-fat/MCT diet.
- Monitor for secondary complications.

✅ Model Answer:
• α1-antitrypsin: A protein that is not absorbed or degraded in the intestine; it is excreted intact in stool when there is protein loss.
• Role:
- Marker of protein-losing enteropathy: Elevated fecal α1-antitrypsin indicates loss of proteins (albumin, immunoglobulins) into the GI tract.
- Distinguishes from: Other causes of hypoalbuminemia (e.g., liver disease, nephrotic syndrome).
• Interpretation:
- Normal: <0.9 mg/g stool.
- Elevated: Suggests protein loss (e.g., intestinal lymphangiectasia, celiac disease, Crohn disease, Menetrier disease).
• Advantages:
- Non-invasive.
- Correlates with the severity of protein loss.
- Useful for monitoring response to treatment.
• Limitations: Falsely elevated in patients with GI bleeding (due to blood proteins in stool).